English & Scottish HTAs Diverge On Sanofi’s Dupixent For Rare Skin Condition

 
• By Francesca Bruce
  
The answer is money
SMC decides whether like Sanofi's Dupixent drugs are value for money • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography